In this issue, we are asking for your reactions in four areas: clinical research standards for the IRP, gene therapy oversight, "plain language" plans, and your own research.
Send your responses on these topics or your comments on other intramural
research concerns to us via e-mail:
<catalyst@nih.gov>;
fax:402-4303; or mail: Building 1, Room 209.
Science in Space: Astrobiology . . .
1.What's your opinion of the new standards for carrying out clinical research at NIH?
2.Do you think there's a need for additional federal oversight of human gene therapy experiments? Should the NIH Recombinant DNA Advisory Committee (RAC) once again have protocol-approving authority, along with the Food and Drug Administration, for gene therapy trials?
3.Do you see how your own writings could benefit from following the guidelines
for "plain language" presented on pages 4 and 5 of this issue?
4.Is there some fascinating research going on in your laboratory you'd like the wider NIH community to know about?
|
PUBLISHER EDITORS Lance
Liotta
|
SCIENTIFIC EDITOR MANAGING EDITOR COPY EDITOR CONTRIBUTING WRITER |
EDITORIAL ADVISORY BOARD Jorge
Carrasquillo, CC
|